Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 43,953 calls trading, 8x expected, and implied vol increasing almost 16 points to 97.34%. Jun-25 6 calls and 6/13 weekly 5 calls are the most active options, with total volume in those strikes near 22,100 contracts. The Put/Call Ratio is 0.05. Earnings are expected on August 7th.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Largest borrow rate increases among liquid names
- Recursion Pharmaceuticals Registers Shares for Resale
- Hold Rating for Recursion Pharmaceuticals Amid Program Discontinuations and Financial Concerns
- Recursion Pharmaceuticals price target lowered to $8 from $10 at BofA
- Cautious Outlook on Recursion Pharmaceuticals Amid Strategic Shifts and Early-Stage Developments